FSD Pharma has come a tremendous rise. FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) recruited another consultant to do a more thorough evaluation of its principal pharmaceutical component, ultramicronized palmitoylethanolamide (PEA), or FSD201, in order to determine its present commercial viability.